From Nasdaq: Akoya Biosciences Inc. (AKYA) has announced a partnership with Thermo Fisher Scientific to combine their RNA solutions to
From GlobeNewswire: Endeavour Mining plc has announced its purchase of 157,286 of its ordinary shares. The lowest price paid per
From Nasdaq: Specialised Therapeutics Asia Pte Ltd. has signed an exclusive agreement with Danish company Ascendis Pharma A/S for distribution
From GlobeNewswire: TGS, PGS, and SLB have secured prefunding to expand seismic data coverage in the Sabah Basin, Malaysia. The
From Barchart: The stock market saw an initial sell-off in 2024, sparking concerns about the market’s future direction. Additionally, the
From Nasdaq: Berkshire Hathaway and Pilot Corp. have reached a full settlement in their Delaware litigation, cancelling a scheduled trial.
From Nasdaq: Indian shares were mixed on Monday as investors considered global market trends and anticipated strong economic growth in
From Quiver Quantitative: Oil prices are declining, influenced by Saudi Aramco’s reduction in official prices. The price of Arab Light
From Dow Jones & Company: Investors believe U.S. bonds are currently a good bet, with consensus on Wall Street that
From Nasdaq: Ultragenyx Pharmaceutical Inc. (RARE) predicts total revenue of $430-435 million for fiscal year 2023, falling slightly short of
From GlobeNewswire: MaxFuse is a new algorithm developed by Akoya Biosciences, in collaboration with Enable Medicine. This algorithm enables the
From NASDAQ: Asian stock markets are trading mostly lower on Monday, despite slightly positive cues from Wall Street on Friday.
From GlobeNewswire: Akoya Biosciences announced their preliminary unaudited revenue for the 4th quarter and full year of 2023. The expected
From Quiver Quantitative: Bond traders have shown a bullish outlook amid speculation of upcoming Federal Reserve rate cuts, leading to
From Nasdaq, Inc.: Castle Biosciences Inc. (CSTL) is on track to generate over $210 million in revenue for fiscal year
From GlobeNewswire: RxSight, an ophthalmic medical device company, announced preliminary unaudited financial results for the fourth quarter and full-year 2023.
From Nasdaq Inc.: Alnylam Pharmaceuticals Inc. reported 40% total TTR annual growth for ONPATTRO and AMVUTTRA in 2023, with global
From GlobeNewswire: Vincerx Pharma, Inc. has announced promising clinical results from a Phase 1 NIH-sponsored study of enitociclib in combination
From Nasdaq: The China stock market has dropped for the second consecutive day by nearly 40 points due to the
From GlobeNewswire: In 2024, Annexon, Inc. will be reaching significant milestones in the development of potential treatments for various diseases.
From Quiver Quantitative: U.S. congressional leaders have agreed on a $1.59 trillion spending cap for fiscal year 2024, reducing the
From Nasdaq: The Singapore stock market ended a three-day slide and finished modestly higher, following gains in the financial and
From Dow Jones & Company, Inc.: Radio and podcast company Audacy Inc. has filed for chapter 11 bankruptcy protection due
From GlobeNewswire: Molecular Partners AG, a biotech company developing cutting-edge DARPin therapeutics, is set to unveil its 2024 outlook at
From Nasdaq: Morgan Stanley (MS) has received a top rating from Validea’s Multi-Factor Investor model based on the strategy of
